Pfizer's Paxlovid antiviral lowered long-Covid risk, suggests study
The research, based on an analysis of electronic health records in databases maintained by the Department of Veterans Affairs, suggests that wider use of Paxlovid won't just stave off critical disease
Pfizer, BioNTech start Covid-flu combination vaccine early-stage study
The single-dose vaccine candidate is a combination of Pfizer's mRNA-based flu shot and the companies' Omicron-tailored Covid-19 booster shot
PFIZER LTD. - 500680 - Board Meeting Intimation for Board Meeting For Consideration And To Take On Record The Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2022.
PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 11, 2022, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022. Pursuant to the 'Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders', the Trading Window of the Company was closed from Friday, September 30, 2022 (close of business) till 48 hours after the results are made public on November 11, 2022. We request you to kindly take the same on record.
Covid vaccine to cost $110-$130 per dose after US govt stops buying: Pfizer
Pfizer will charge USD 110 to USD 130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots, but the drugmaker says it expects many people will continue receiving it for free. Pfizer executives said the commercial pricing for adult doses could start early next year, depending on when the government phases out its program of buying and distributing the shots. The drugmaker said it expects that people with private health insurance or coverage through public programs like Medicare or Medicaid will pay nothing. The Affordable Care Act requires insurers to cover many recommended vaccines without charging any out-of-pocket expenses. A spokesman said the company also has an income-based assistance program that helps eligible U.S. residents with no insurance get the shots. The price would make the two-dose vaccine more expensive for cash-paying customers than annual flu shots. Those can range in price from around $50 to $95, depending on the type, according to US FDA authorises updated Moderna, Pfizer Covid boosters for children
The US Food and Drug Administration (FDA) has authorised the updated Moderna and Pfizer-BioNTech Covid-19 booster shots for children as young as five PFIZER LTD. - 500680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we furnish herewith Certificate dated October 12, 2022, issued by KFin Technologies Limited, Registrar and Share Transfer Agent of the Company for the quarter ended September 30, 2022. PFIZER LTD. - 500680 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 036360 Name of the Signatory :- Prajeet NairDesignation :- Company Secretary and Compliance Officer PFIZER LTD. - 500680 - Closure of Trading Window
We would like to inform you that, for the purpose of declaration of unaudited financial results of the Company, for the quarter and half year ended September 30, 2022, the trading window of the Company shall remain closed from Friday, September 30, 2022 (close of business) till 48 hours after the results are made public. We request you to kindly take the above on record. PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Limited has received requests for issue of duplicate Share Certificate(s) from Shareholder(s). We shall issue the letter of confirmation(s) upon completion of necessary formalities by the shareholder(s). Please take the above on record
After 30 special dividend, pharma stock trades ex-dividend
Pfizer's board at meeting held on September 6, 2022 declared an Interim (Special) Dividend of 30 per equity share